CD19 and systemic lupus erythematosus: To further investigate the protective effects of the monoclonal anti‐CD19 antibodies on lupus mice after the depletion of CD19+ B cells and plasma cells, we evaluated the histological and pathological changes of skin and kidneys in three groups.